Literature DB >> 27928163

TBCD may be a causal gene in progressive neurodegenerative encephalopathy with atypical infantile spinal muscular atrophy.

Toshio Ikeda1, Akihiko Nakahara2, Rie Nagano3, Maiko Utoyama1, Megumi Obara1, Hiroshi Moritake1, Tamayo Uechi4, Jun Mitsui5, Hiroyuki Ishiura5, Jun Yoshimura6, Koichiro Doi6, Naoya Kenmochi4, Shinichi Morishita6, Ichizo Nishino7, Shoji Tsuji5, Hiroyuki Nunoi1.   

Abstract

Spinal muscular atrophy (SMA) is an autosomal recessive neurodegenerative disorder caused by survival motor neuron gene mutations. Variant forms of SMA accompanied by additional clinical presentations have been classified as atypical SMA and are thought to be caused by variants in as yet unidentified causative genes. Here, we presented the clinical findings of two siblings with an SMA variant followed by progressive cerebral atrophy, and the results of whole-exome sequencing analyses of the family quartet that was performed to identify potential causative variants. We identified two candidate homozygous missense variants, R942Q in the tubulin-folding cofactor D (TBCD) gene and H250Q in the bromo-adjacent homology domain and coiled-coil containing 1 (BAHCC1) gene, located on chromosome 17q25.3 with an interval of 1.4 Mbp. The in silico analysis of both variants suggested that TBCD rather than BAHCC1 was likely the pathogenic gene (TBCD sensitivity, 0.68; specificity, 0.97; BAHCC1 sensitivity, 1.00; specificity, 0.00). Thus, our results show that TBCD is a likely novel candidate gene for atypical SMA with progressive cerebral atrophy. TBCD is predicted to have important functions on tubulin integrity in motor neurons as well as in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27928163     DOI: 10.1038/jhg.2016.149

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  6 in total

1.  A Faroese founder variant in TBCD causes early onset, progressive encephalopathy with a homogenous clinical course.

Authors:  Sabine Grønborg; Lotte Risom; Jakob Ek; Karen Bonde Larsen; David Scheie; Yanko Petkov; Vibeke André Larsen; Morten Dunø; Fróði Joensen; Elsebet Østergaard
Journal:  Eur J Hum Genet       Date:  2018-06-19       Impact factor: 4.246

2.  A Trimer Consisting of the Tubulin-specific Chaperone D (TBCD), Regulatory GTPase ARL2, and β-Tubulin Is Required for Maintaining the Microtubule Network.

Authors:  Joshua W Francis; Laura E Newman; Leslie A Cunningham; Richard A Kahn
Journal:  J Biol Chem       Date:  2017-01-26       Impact factor: 5.157

3.  Biallelic pathogenic variants in TBCD-related neurodevelopment disease with mild clinical features.

Authors:  Di Tian; Khan Rizwan; Yi Liu; Lulu Kang; Yanlin Yang; Xiao Mao; Li Shu
Journal:  Neurol Sci       Date:  2019-06-25       Impact factor: 3.307

4.  Nucleotide Binding to ARL2 in the TBCD∙ARL2∙β-Tubulin Complex Drives Conformational Changes in β-Tubulin.

Authors:  Joshua W Francis; Devrishi Goswami; Scott J Novick; Bruce D Pascal; Emily R Weikum; Eric A Ortlund; Patrick R Griffin; Richard A Kahn
Journal:  J Mol Biol       Date:  2017-09-29       Impact factor: 5.469

Review 5.  Clinical Application of Genome and Exome Sequencing as a Diagnostic Tool for Pediatric Patients: a Scoping Review of the Literature.

Authors:  Hadley Stevens Smith; J Michael Swint; Seema R Lalani; Jose-Miguel Yamal; Marcia C de Oliveira Otto; Stephan Castellanos; Amy Taylor; Brendan H Lee; Heidi V Russell
Journal:  Genet Med       Date:  2018-05-14       Impact factor: 8.822

6.  Novel Compound Heterozygous Variants in TBCD Gene Associated with Infantile Neurodegenerative Encephalopathy.

Authors:  Chih-Ling Chen; Chien-Nan Lee; Yin-Hsiu Chien; Wuh-Liang Hwu; Tung-Ming Chang; Ni-Chung Lee
Journal:  Children (Basel)       Date:  2021-12-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.